Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT02783950Not ApplicableCompleted

Genomics in Michigan Impacting Observation or Radiation

Role: collaborator

NCT02609269Enrolling By Invitation

Decipher Genomics Resource for Intelligent Discovery

Role: lead

NCT02080689Not ApplicableCompleted

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

Role: lead

NCT02034825Completed

Multi-site Decision Impact Study for Decipher

Role: lead

NCT02034812Completed

Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations for Radiation Oncologists

Role: lead

NCT02020876Completed

Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations

Role: lead

All 6 trials loaded